• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Drugs of today: Medicamentos de actualidad >The Financial Times Global Pharmaceutical and Biotechnology Conference. Embracing Disruption for a New Era in Health (November 5-6, 2018 - London, UK.
【24h】

The Financial Times Global Pharmaceutical and Biotechnology Conference. Embracing Disruption for a New Era in Health (November 5-6, 2018 - London, UK.

机译：金融时报全球制药和生物技术会议。 拥抱健康新时代的破坏（2018年11月5日至6日 - 英国伦敦。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The Financial Times (FT) Global Healthcare conference brought together top-level executives and leaders in global healthcare and technology around a fascinating and thought-provoking agenda. Consisting of a wide range of expert panel discussions chaired by the FT and Deloitte's specialist editors, as well as a series of keynote CEO interviews, the conference took an in-depth and nuanced view of the forces of disruption colliding in healthcare at the moment. Gains in R+D are implicit, but beyond this, technology and data disruption can potentially transform all aspects of healthcare through patient-centered care, the march of big data, advanced analytics and the entrance of new players in the market such as technology firms and app providers. While the economics may be intrinsically challenging, and uncertainty and complexity are inherent throughout, the FT conference assembled visionaries of this healthcare future providing a captivating insight of the forces which are so fundamentally altering the structure of the industry.
机译：金融时报（FT）全球医疗保健会议在全球医疗保健和技术统治着令人欣赏和挑衅挑衅议程的全球医疗保健和技术中汇集了顶级高管和领导者。由FT和Deloitte的专家编辑主持的各种专家小组讨论，以及一系列主题演讲机采访，该会议目前对医疗保健的破坏力量进行了深入深入和细致的观点。 R + D中的收益是隐式的，但除此之外，技术和数据中断可能通过患者中心护理，大数据，高级分析和新参与者在技术公司等市场的进程中潜在地改变医疗保健的所有方面和应用程序提供商。虽然经济学可能是本质上的挑战性，但不确定性和复杂性是始终固有的，这是这种医疗保健未来的FT会议组装的Visionies，提供了对这些力量改变行业结构的迷人洞察力。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号